Literature DB >> 24021269

PET-CT after radiofrequency ablation of colorectal liver metastases: suggestions for timing and image interpretation.

Karin Nielsen1, Aukje A J M van Tilborg, Hester J Scheffer, Martijn R Meijerink, Elly S M de Lange-de Klerk, Sybren Meijer, Emile F I Comans, M Petrousjka van den Tol.   

Abstract

INTRODUCTION: The main area of concern regarding radiofrequency ablation (RFA) of colorectal liver metastases is the risk of developing a local site recurrence (LSR). Reported accuracy of PET-CT in detecting LSR is high compared to morphological imaging alone, but no internationally accepted criteria for image interpretation have been defined. Our aim was to assess criteria for FDG PET-CT image interpretation following RFA, and to define a timetable for follow-up detection of LSR.
METHODS: Patients who underwent RFA for colorectal liver metastases between 2005 and 2011, with FDG-PET follow-up within one year after treatment were included. Results of repeat FDG-PET scans were evaluated until a LSR was diagnosed. Results. One hundred-seventy scans were obtained for 79 patients (179 lesions), 57 scans (72%) were obtained within 6 months of treatment. Thirty patients developed local recurrence; 29 (97%) within 1 year. Only 2% of lesions of <1cm and 4% of <2 cm showed a LSR.
CONCLUSION: The majority of local site recurrences are diagnosed within one year after RFA. Regular follow-up using FDG PET-CT within this period is advised, so repeated treatment can be initiated. Rim-shaped uptake may be present until 4-6 months, complicating evaluation. The benefit in the follow-up of lesions <2 cm may be limited.
Copyright © 2013 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  FDG-PET; Liver Neoplasms/surgery; Liver neoplasms/secondary; Local; Neoplasm recurrence; Radiofrequency ablation

Mesh:

Year:  2013        PMID: 24021269     DOI: 10.1016/j.ejrad.2013.08.024

Source DB:  PubMed          Journal:  Eur J Radiol        ISSN: 0720-048X            Impact factor:   3.528


  7 in total

1.  18F-FDG PET/CT Is an Immediate Imaging Biomarker of Treatment Success After Liver Metastasis Ablation.

Authors:  Francois Cornelis; Vlasios Sotirchos; Elena Violari; Constantinos T Sofocleous; Heiko Schoder; Jeremy C Durack; Robert H Siegelbaum; Majid Maybody; John Humm; Stephen B Solomon
Journal:  J Nucl Med       Date:  2016-02-23       Impact factor: 10.057

Review 2.  The Role of PET Imaging Before, During, and After Percutaneous Hepatic and Pulmonary Tumor Ablation.

Authors:  Eric D McLoney; Ari J Isaacson; Patrick Keating
Journal:  Semin Intervent Radiol       Date:  2014-06       Impact factor: 1.513

3.  Immediate Postablation 18F-FDG Injection and Corresponding SUV Are Surrogate Biomarkers of Local Tumor Progression After Thermal Ablation of Colorectal Carcinoma Liver Metastases.

Authors:  Francois H Cornelis; Elena N Petre; Efsevia Vakiani; David Klimstra; Jeremy C Durack; Mithat Gonen; Joseph Osborne; Stephen B Solomon; Constantinos T Sofocleous
Journal:  J Nucl Med       Date:  2018-02-09       Impact factor: 10.057

4.  Colorectal liver metastatic disease: efficacy of irreversible electroporation--a single-arm phase II clinical trial (COLDFIRE-2 trial).

Authors:  Hester J Scheffer; Laurien G P H Vroomen; Karin Nielsen; Aukje A J M van Tilborg; Emile F I Comans; Cornelis van Kuijk; Bram B van der Meijs; Janneke van den Bergh; Petrousjka M P van den Tol; Martijn R Meijerink
Journal:  BMC Cancer       Date:  2015-10-24       Impact factor: 4.430

5.  The use of PET-MRI in the follow-up after radiofrequency- and microwave ablation of colorectal liver metastases.

Authors:  Karin Nielsen; Hester J Scheffer; Indra C Pieters; Aukje A J M van Tilborg; Jan-Hein T M van Waesberghe; Daniela E Oprea-Lager; Martijn R Meijerink; Geert Kazemier; Otto S Hoekstra; Hermien W H Schreurs; Colin Sietses; Sybren Meijer; Emile F I Comans; Petrousjka M P van den Tol
Journal:  BMC Med Imaging       Date:  2014-08-08       Impact factor: 1.930

6.  MWA Versus RFA for Perivascular and Peribiliary CRLM: A Retrospective Patient- and Lesion-Based Analysis of Two Historical Cohorts.

Authors:  Aukje A J M van Tilborg; Hester J Scheffer; Marcus C de Jong; Laurien G P H Vroomen; Karin Nielsen; Cornelis van Kuijk; Petrousjka M P van den Tol; Martijn R Meijerink
Journal:  Cardiovasc Intervent Radiol       Date:  2016-07-07       Impact factor: 2.740

Review 7.  The Value of 18F-FDG-PET-CT Imaging in Treatment Evaluation of Colorectal Liver Metastases: A Systematic Review.

Authors:  Okker D Bijlstra; Maud M E Boreel; Sietse van Mossel; Mark C Burgmans; Ellen H W Kapiteijn; Daniela E Oprea-Lager; Daphne D D Rietbergen; Floris H P van Velden; Alexander L Vahrmeijer; Rutger-Jan Swijnenburg; J Sven D Mieog; Lioe-Fee de Geus-Oei
Journal:  Diagnostics (Basel)       Date:  2022-03-15
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.